⌘K

Home/Insiders/Hefti Franz

HF

SEC Insider//CIK 0001735529

Hefti Franz

CIK 00017355291 companyNEW YORK, NY

Transactions

4

Companies

1

Filings

2

CIK

0001735529

Recent Transactions

4 trades

Disposition to Issuer
Prevail Therapeutics Inc.
Stock Option (Right to Buy)
2021-01-22−59,844→ 0 total
Disposition to Issuer
Prevail Therapeutics Inc.
Stock Option (Right to Buy)
2021-01-22−266,895→ 0 total
Disposition to Issuer
Prevail Therapeutics Inc.
Stock Option (Right to Buy)
2021-01-22−62,200→ 0 total
Award
Prevail Therapeutics Inc.
Stock Option (Right to Buy)
2020-02-19+62,200→ 62,200 total

Companies

1

Prevail Therapeutics Inc.
Chief Development Officer

Recent Filings

2

Address

C/O PREVAIL THERAPEUTICS INC. 430 EAST 29TH STREET, SUITE 940

NEW YORK, NY, 10016

View on SEC.gov